High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma

被引：0
作者：
Roya Ghods
Mohammad-Hossein Ghahremani
Zahra Madjd
Mojgan Asgari
Maryam Abolhasani
Sanaz Tavasoli
Ahmad-Reza Mahmoudi
Maryam Darzi
Parvin Pasalar
Mahmood Jeddi-Tehrani
Amir-Hassan Zarnani
机构：
[1] Tehran University of Medical Sciences,Department of Molecular Medicine, School of Advanced Medical Technologies
[2] TUMS,Monoclonal Antibody Research Center
[3] Avicenna Research Institute,Department of Pharmacology
[4] ACECR,Toxicology, Faculty of Medicine
[5] Tehran University of Medical Sciences,Oncopathology Research Center
[6] TUMS,Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine
[7] Iran University of Medical Sciences,Department of Pathology, Hasheminejad Kidney Center
[8] IUMS,Department of Nutrition, Science and Research Branch
[9] Iran University of Medical Sciences,Immunology Research Center
[10] IUMS,Nanobiotechnology Research Center
[11] Iran University of Medical Sciences,undefined
[12] IUMS,undefined
[13] Azad University,undefined
[14] Iran University of Medical Sciences,undefined
[15] IUMS,undefined
[16] Avicenna Research Institute,undefined
[17] ACECR,undefined
[18] School of Advanced Technologies in Medicine,undefined
来源：
Cancer Immunology, Immunotherapy | 2014年 / 63卷
关键词：
Immunohistochemistry; Gleason; PLAC1; Prostate cancer; PSA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1319 / 1327
页数：8
相关论文
共 207 条
[1]  
Slovin SR(2012)Toward maximizing immunotherapy in metastatic castration-resistant prostate cancer–rationale for combinatorial approaches using chemotherapy Front Oncol 2 43-960
[2]  
Agarwal N(2012)Novel molecular targets for the therapy of castration-resistant prostate cancer Eur Urol 61 950-561
[3]  
Sonpavde G(2011)Immunotherapy for the treatment of prostate cancer Nat Rev Clin Oncol 8 551-306
[4]  
Sternberg CN(2009)Prostate cancer stem cells J Pathol 217 299-10951
[5]  
Di Lorenzo G(2005)Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 10946-1708
[6]  
Buonerba C(2006)Highly purified CD44 + prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells Oncogene 25 1696-6805
[7]  
Kantoff PW(2007)Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44 + alpha2beta1 + cell population is enriched in tumor-initiating cells Cancer Res 67 6796-254
[8]  
Lang SH(2010)Stem cell characteristics in prostate cancer cell lines Eur Urol 57 246-46
[9]  
Frame FM(1988)Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands Prostate 12 39-770
[10]  
Collins AT(1986)Carcinoma of the prostate with atypical immunohistological features: clinical and histologic correlates Am J Surg Pathol 10 765-187
12345678910